A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografische gegevens
Hoofdauteur:	Islam, Saidul
Andere auteurs:	Sharmin, Shahana
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2022
Onderwerpen:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Online toegang:	http://hdl.handle.net/10361/17308

Gelijkaardige items

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
door: Karim, Azrin
Gepubliceerd in: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Flora, Sanzida Alam
Gepubliceerd in: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
door: Meem, Manila
Gepubliceerd in: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
door: Alam, Tahera
Gepubliceerd in: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
door: Ahmed, Nafisa
Gepubliceerd in: (2023)

A review on triple-negative breast cancer and its potential treatment
door: Niasa, Jannatul Ferdous
Gepubliceerd in: (2023)

Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
door: Khan, Muidul Hasan
Gepubliceerd in: (2024)

Stem cells as therapeutic carrier in cancer treatment
door: Anika, Mysha Yeasmin
Gepubliceerd in: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
door: Hasan, Amit
Gepubliceerd in: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
door: Chakraborty, Anuradha
Gepubliceerd in: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
door: Ratu, Tabassum
Gepubliceerd in: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
door: Roy, Hredita
Gepubliceerd in: (2018)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
door: Shaikat, Mahdi Mubin
Gepubliceerd in: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
door: Khondokar, Faiza
Gepubliceerd in: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
door: Emon, Kamrul Hasan
Gepubliceerd in: (2022)

Biosimilar in lymphoma treatment
door: Tanisha, Mehrin Haque
Gepubliceerd in: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
door: Khan, Rezia Nowrin
Gepubliceerd in: (2021)

Targeting BRAFV600E in the treatment of CRC
door: Roja, Mashwiyat Samrin
Gepubliceerd in: (2024)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
door: Muntaha, Habibatul
Gepubliceerd in: (2023)

Potential of liposomes for the treatment of lung cancer- a review
door: Mim, Shanzida
Gepubliceerd in: (2023)

Recent advancement on breast cancer detection and treatment
door: Rahman, Sanjida
Gepubliceerd in: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
door: Nuha, Nabiha Tahsin
Gepubliceerd in: (2024)

Role of statins as antagonists of SPARC in gastric cancer
door: Shahmat, Rad
Gepubliceerd in: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
door: Sorno, Rubina Haque
Gepubliceerd in: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
door: Choki, Kinley
Gepubliceerd in: (2024)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
door: Ahmed, Kazi Zeba
Gepubliceerd in: (2021)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
door: Mirza, Maisa Tasnim
Gepubliceerd in: (2023)

A comprehensive review on drug repurposing in cancer treatment
door: Sarkar, Onusree
Gepubliceerd in: (2024)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
door: Rahman, Qazi Ashrafur
Gepubliceerd in: (2018)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
door: Abir, Shifaty Nur
Gepubliceerd in: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
door: Hossain, Safa Binte
Gepubliceerd in: (2019)

ক্যান্সার : মৃত্যু অবধারিত নয় /
door: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
door: Nawar, Anika
Gepubliceerd in: (2019)

Natural products and their combinatory effects in breast cancer treatment
door: Siddique, Md. Ayman
Gepubliceerd in: (2021)

Statistics and informatics in molecular cancer research

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
door: Rahman, Tasnim
Gepubliceerd in: (2024)

Identification of FAP inhibitors using in silico simulation study
door: Deeba, Maliha Tasnim
Gepubliceerd in: (2018)

Targeted therapeutic options in the treatment of Breast Cancer
door: Alam, Kazi Tasnuva
Gepubliceerd in: (2022)